Sichuan Kelun-Biotech Plans Full H Share Circulation
Company Announcements

Sichuan Kelun-Biotech Plans Full H Share Circulation

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is moving forward with full circulation of its H shares, representing 0.52% of the company’s total share capital, pending necessary approvals and regulatory procedures. This strategic maneuver aims to enhance the liquidity of shares and is in line with guidelines set by the China Securities Regulatory Commission. Investors are advised to be cautious and stay tuned for further announcements regarding the progress of this initiative.

For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App